Carta al Editor
Réplica. Lopinavir/ritonavir en monoterapia: ¿para quién y cuándo?Author's response. Lopinavir/ritonavir monotherapy: For whom and when?

https://doi.org/10.1016/j.eimc.2009.06.007Get rights and content

Bibliografía (10)

  • M.E. Valencia et al.

    De la investigación a la práctica clínica: uso de lopinavir/ritonavir en monoterapia

    Enferm Infecc Mioclobiol Clin

    (2008)
  • Tratamiento de simplificación: lopinavir/ritonavir con o sin efavirenz. Enferm Infecc Microbiol Clin;...
  • J.R. Arribas et al.

    Lopinavir/ritonavir as a single-drug Therapy for manteinance of HIV-1 viral suppression: 48-weeks results of a randomized, controlled, open-label, proof-of-concept pilot clinical trial (OK Study)

    J Aquir Immune Defic Syndr

    (2005)
  • Arribas JR, Pulido F, Delgado R, Cabrero E, Cepeda C, González-García J, et al. Lopinavir/ritonavir as single-drug...
  • Riddler SA, Haubrich R, DiRienzo G, Peeples L, Powderly WG, Klingman KL. AIDS Clinical Trials Group 5142 Study Team. A...
There are more references available in the full text version of this article.

Cited by (0)

View full text